CD8A and neoplasm: Vargas et al. found that combining Fc-optimised anti-CD25 treatment and anti-PD-1 antagonists could eradicate solid cancers (advanced kidney cancer and melanoma) by depleting tumour-infiltrating Tregs, which usually downregulate the proliferation of CD8+ T cells [34].